ARCHIVES

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Interim Analysis Suggests Paclical Can Reduce Blood Levels

August 26, 2011

NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas

January 23, 1987

Clinton R&D Budget Amounts to a Cut, AAAS Study Says

April 18, 1997

Funding Opportunities

February 7, 2003

Managed Care: “Natural Alliance” Between Managed Care And Academic Centers, McGivney Says

January 24, 1997

AACR Opposes Human Life Bill; ASCO Backs Cancer Act, Reimbursement

May 8, 1981